hca glp 1 coverage Your Weight-Loss Drugs Are Next on the Corporate Chopping Block MCT2D | 2023 Updates to

While medications known as GLP-1, or glucagon-like peptide-1 receptor agonists, were originally created for the treatment of diabetes, they are now often used for weight loss management

CMS initially stated that for future model years, the agency was considering additional payment incentives, including higher direct subsidy payments based on an adjustment factor to the beneficiary risk score in participating plan bids

Another two trials from the SURMOUNT programme have recently been published [48, 49]

For patients focused on stronger weight loss, standard-dose semaglutide or tirzepatide may be the better starting point